Enrolment T0 | Baseline T1 | FU3m T2 | FU6m T3 | |
Eligibility screen | X | |||
Informed consent | X | |||
Allocation | X | |||
PATHway intervention | ||||
Usual care (control) intervention | ||||
Assessments | ||||
Physical activity | X | X | X | |
Demographic characteristics | X | X | ||
Health-related physical fitness | ||||
CPET | X | X | X | |
Muscle strength and flexibility | X | X | X | |
Quality of the vascular system | X | X | X | |
Blood sampling | X | X | ||
Body composition | X | X | X | |
Health-related QoL and psychosocial well-being | ||||
PHQ-9 | X | X | X | |
EQ-5D-5L questionnaire | X | X | x | |
SF-36 questionnaire | X | X | X | |
Exercise self-efficacy scale | X | X | X | |
Medication adherence | X | X | X | |
Exercise barriers | X | X | X | |
Perceived stress scale | X | X | X | |
ENRICHD | X | X | X | |
Satisfaction/usability tests | X | |||
Resource use data collection | X | X | X | |
Safety monitoring | ||||
Three-day ECG Holter monitoring | X | X | X | |
Adverse event reporting | ||||
Process evaluation (assessment of DSS) | ||||
Validation of DSS outcomes captured in reports by clinical experts | X | X | X |
Satisfaction/usability test will only be performed in the intervention group.
CPET, cardiopulmonary exercise test; DSS, decision support system; ENRICHD, Enhancing Recovery In Coronary Heart Disease; EQ-5D-5L, EuroQol-Five Dimensions-Five Levels Questionnaire; PHQ-9, Patient Health Questionnaire 9; QoL, Quality of Life; SF-36, Short Form 36; T, timepoint.